CML, Organ Music and Cherry Blossoms in Trondheim: Report from the NCMLSG Symposium, 23–24 April 2026 In late April, the Nordic CML Study Group (NCMLSG) gathered for a two-day meeting on the banks of
You may register at via this link to the NCMLSG education symposium, school and group meeting here. Most welcome! See also “Events” page. Registration to the event For those who want to become or stay
Sign up for a user account for quicker registrations, and access member-only materials and updates. Getting started is simple: choose Register on the site, enter your email, and confirm it through the link we
Our events bring together clinicians, nurses, scientists, and partners to share the latest in CML care and research. Explore the calendar, learn more about each session, and secure your spot with quick registration.
We aim is to cure CML patients without allogeneic transplantation and improve treatment of CML .
Our group consists of scientists, clinicians and nurses interested in CML. We work all over the Nordic region, mainly at University Hospitals but also hematologists working in other hospitals are active in our group. We meet twice a year (generally April and November).
Our activities have been supported by partners in pharmaceutical industry, and we regard this cooperation as an essential element for progress
We will pursue our aim by conducting clinical trials and attached to such trials address scientific questions in the laboratory. Sampling of patient material during trials is key to solve scientific problems that may direct us toward new treatments.
Our clinical trials have been focused on use of different tyrosine kinase inhibitors, also combined with pegylated interferon. For patients who do well we have participated in discontinuation projects (we contributed 25% of patients to the big EuroSKI project, an European LeukemiaNet study. See http://www.leukemia-net.org
Guideline-based treatment depends on excellent assessment of disease burden. Standardization efforts for PCR measurement of residual disease have been carried out and continue in anEuropean framework (EUTOS).
Spread of knowledge through education activities, with CML school for young hematologists and an open CML Education Symposium have been arranged every second year. Treatment guidelines have been issued in all countries and on the European level.
Henrik Hjorth-Hansen,
NCMLSG – chairman
The Nordic CML Study Group (NCMLSG) is guided by a dedicated team of experts in hematology, research, and clinical practice. Our steering group consists of leading specialists from across the Nordic region, committed to advancing the treatment of Chronic Myeloid Leukemia (CML).
Chairman, Trondheim
Helsinki
Roskilde
We are committed to advancing medical knowledge and collaboration. Whether you have questions, wish to contribute, or need further information about our study group, we’d love to hear from you. Connect with us to join a network of dedicated professionals striving for excellence in healthcare.